What Is Tirzepatide?
Tirzepatide, a revolutionary medication primarily developed for the treatment of type 2 diabetes, is making waves due to its excellent additional effectivity for weight loss. In fact, it is the fastest-growing drug of 2024, with $5.1 billion in combined revenue in the first half of the year. If you're wondering how to get tirzepatide, it's important to know that in the US, it is sold under the branded names Mounjaro and Zepbound.
Tirezepatide works by targeting two critical hormones involved in regulating blood sugar and body weight, called GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
GLP-1 and GIP are hormones that the body naturally releases after eating to help control blood sugar levels. They work by:
Stimulating insulin release,
Reducing sugar production in the liver, and
Slowing down the speed at which food leaves the stomach.
Tirzepatide is very similar to the active substance of the other well-known diabetes and weight loss drug, semaglutide (branded as Ozempic). Unlike Ozempic, however, which targets only the GLP-1 receptor, tirzepatide activates both the GLP-1 and GIP receptors.
This dual action is thought to boost these natural processes more effectively, helping to manage blood sugar levels and support weight loss by reducing appetite and promoting a feeling of fullness.